Voluntary announcement InSilico Medicine entered into an AI co-development collaboration with a contract value up to tens of millions of U.S. dollars to build and commercialize foundation models for biology
Filed with HKEX · Stock code 3696 · · 2 pages · English
CHEMICAL SCIENCE INSILICO MEDICINE InSilico Medicine Cayman TopCo英矽智能 (Incorporated in the Cayman Islands with limited liability) (Stock code: 3696) VOLUNTARY ANNOUNCEMENT INSILICO MEDICINE ENTERED INTO AN AI CO-DEVELOPMENT ## COLLABORATION WITH A CONTRACT VALUE UP TO TENS OF MILLIONS OF U.S. DOLLARS TO BUILD AND COMMERCIALIZE ## FOUNDATION MODELS FOR BIOLOGY This announcement is made by InSilico
InSilico Medicine Cayman TopCo on 6ix
Earlier from InSilico Medicine Cayman TopCo
- Insilico Medicine Opens AI Longevity Discovery Toolkit to Researchers Worldwide in Cell Cover Study
- Voluntary announcement increase in shareholding by chairman of the board
- Insilico Medicine Doses First Patient in GENESIS-IPF-3, the World's First Phase III Trial of a Generative AI-Driven Innovative Drug
- Insilico Medicine Included in the HKEX Tech 100 Index, Drawing Attention to Opportunities in AI Value Chain
- Commercialization Roadmap Validated with Three-digit Million-dollar Revenue, Insilico Medicine Announces Interim Results for the First Half of 2026
Later from InSilico Medicine Cayman TopCo
- Voluntary announcement InSilico Medicine nominates next-generation small molecule GIPR antagonist for potential intervention of obesity and related disorders
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Voluntary announcement InSilico Medicine nominates peripheral-restricted VAV1 molecular glue degrader for potential treatment of autoimmune diseases
- Voluntary announcement InSilico Medicine triggers a milestone payment in AI-driven R&D collaboration with servier for achieving early drug discovery milestone
Follow InSilico Medicine Cayman TopCo into a list and get an email when it puts out news.
Follow InSilico Medicine Cayman TopCo